Evidence map›Paper›PMID 40369603›Full record

ArticleBMC biology2025

Bio-informed synthesis of marine-sourced indole derivatives: suppressing gram-negative bacteria biofilm and virulence.

Karina Golberg, Kamal Elouarzaki, Bat-El Kagan, Marilou Shagan, Netta Shemesh, Esti Kramarsky-Winter, Anat Ben-Zvi, Yaffa Mizrachi Nebenzahl, Robert S Marks, Ariel Kushmaro

Abstract read
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karina Golberg *Department of Biotechnology Engineering, Avram and Stella Goldstein-Goren, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.ORCID http://orcid.org/0009-0007-6216-2530
Kamal Elouarzaki *School of Materials Science and Engineering and Center for Advanced Catalysis Science and Technology, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798, Singapore.
Bat-El KaganDepartment of Biotechnology Engineering, Avram and Stella Goldstein-Goren, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Marilou ShaganDepartment of Biotechnology Engineering, Avram and Stella Goldstein-Goren, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Netta ShemeshDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Esti Kramarsky-WinterDepartment of Biotechnology Engineering, Avram and Stella Goldstein-Goren, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Anat Ben-ZviDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Yaffa Mizrachi NebenzahlPediatric Infectious Disease Unit, Faculty of Health Science, Soroka University Medical Center, Beer-Sheva, 84105, Israel.
Robert S MarksDepartment of Biotechnology Engineering, Avram and Stella Goldstein-Goren, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Ariel KushmaroDepartment of Biotechnology Engineering, Avram and Stella Goldstein-Goren, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel. arielkus@bgu.ac.il.

Funding

NIBN 8528620
6 · The paper itself

Abstract

Biofilms cling to surfaces to form complex architectures allowing their bacterial creators to acquire multidrug resistance and claiming countless lives worldwide. Therefore, finding novel compounds that affect virulence and biofilm-forming capacity of resistant pathogenic bacteria is imperative. Recently, we identified indole-based compounds that possess anti-biofilm properties in coral-associated bacteria. We succeeded in efficiently synthesizing two of these compounds, 1,1'-bisindole (NN) and 2,3-dihydro-2,2'-bisindole (DIV). They were found to attenuate biofilms of gram-negative bacterial pathogens, including Pseudomonas aeruginosa and Acinetobacter baumannii. Combining these compounds with the antibiotic tobramycin resulted in significant biofilm inhibition, particularly in the eradication of mature P. aeruginosa biofilms. Both of the bisindole derivatives, suppressed a number of bacterial virulence factors, reduced bacterial adhesion, and improved survival rates in infected Caenorhabditis elegans and human lung epithelial cell models. Transcriptome analyses of the bacteria treated with these compounds revealed that NN repressed or upregulated 307 genes when compared to untreated P. aeruginosa. These bacteria-derived molecules act in resistance-quenching and are potentially important candidates for inclusion in treatment protocols. The use of compounds that prevent the biofilm from accumulating the high cell densities critical to its structural and functional maintenance represents significant progress in the management of bacterial persistence. Therefore, a possible clinical implementation of these innovative compounds holds a promising future.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBiofilmsGram-Negative BacteriaIndolesPseudomonas aeruginosaAnimalsCaenorhabditis elegansHumansVirulenceAnti-Bacterial AgentsIndolesAntibioticsBiofilm eradicationBis-indolesChemical biologyResistance

Identifiers

PMID40369603
PMCPMC12079825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.